Example: Heart Attack

Clinical Trials on Hemorrhage

Total 4521 results

    • NCT04027920
      Completed
      Postpartum Hemorrhage After Shenghua Decoction Treatment
      Conditions: Postpartum Hemorrhage
    • NCT04364386
      Completed
      Feasibility Clinical Investigation Using the InPress Device for the Treatment of Postpartum Hemorrhage
      Conditions: Post Partum Hemorrhage
    • NCT03344744
      Recruiting
      miRNA Profile in Aneurysmal Subarachnoid Haemorrhage
      Conditions: Subarachnoid Hemorrhage
    • NCT02883673
      Completed
      Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
      Conditions: Postpartum Hemorrhage
    • NCT03326596
      Unknown status
      Prevention of Postpartum Hemorrhage With TXA
      Conditions: Postpartum Hemorrhage
    • NCT03442491
      Not yet recruiting
      Hayman's Haemostatic Suture to Treat Severe Post-partum Haemorrhage
      Conditions: Postpartum Hemorrhage
    • NCT03287336
      Active, not recruiting
      Prevention of Postpartum Hemorrhage With Tranexamic Acid
      Conditions: Postpartum Hemorrhage
    • NCT04707950
      Recruiting
      Tranexamic Acid for the Prevention of Postpartum Haemorrhage
      Conditions: Postpartum Hemorrhage
    • NCT04463966
      Recruiting
      Prevention of Postpartum Haemorrhage
      Conditions: Post Partum Hemorrhage
    • NCT01747408
      Terminated
      Treatment of Subarachnoid Hemorrhage With Human Albumin
      Conditions: Subarachnoid Hemorrhage
    • NCT04733157
      Not yet recruiting
      The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section
      Conditions: Postpartum Hemorrhage
    • NCT04052646
      Completed
      Prehospital Deaths From Spontaneous Subarachnoid Haemorrhages
      Conditions: Subarachnoid Hemorrhage
    • NCT03479112
      Completed
      Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial
      Conditions: Traumatic Hemorrhage
    • NCT02687191
      Terminated
      Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
      Conditions: Intracerebral Hemorrhage
    • NCT03930940
      Completed
      Remote Ischemic Conditioning for Intracerebral Hemorrhage
      Conditions: Intracerebral Hemorrhage
    • NCT01600612
      Unknown status
      Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial
      Conditions: Postpartum Hemorrhage
    • NCT03737344
      Recruiting
      BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
      Conditions: Intracerebral Haemorrhage
    • NCT01320423
      Unknown status
      Surgical Trial in Lobar Intracerebral Haemorrhage
      Conditions: Intracerebral Haemorrhage
    • NCT03569540
      Unknown status
      Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage
      Conditions: Subarachnoid Hemorrhage, Aneurysmal
    • NCT02672891
      Completed
      Intrauterine Balloon Tamponade in the Management of Postpartum Hemorrhage
      Conditions: Postpartum Hemorrhage
    • NCT03815513
      Unknown status
      Non-invasive Evaluation of Cerebrovascular Reactivity in Spontaneous Intracerebral Hemorrhage
      Conditions: Intracerebral Hemorrhage
    • NCT04042571
      Recruiting
      Permanent Cerebral Oxymetry Monitoring for Early Diagnosis and Treatment of Delayed Vasospasm After Subarachnoid Hemorrhage
      Conditions: Subarachnoid Hemorrhage
    • NCT02416089
      Terminated
      Tampostat for Management of Postpartum Hemorrhage
      Conditions: Postpartum Hemorrhage
    • NCT01971359
      Completed
      Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
      Conditions: Intracerebral Hemorrhage
    • NCT04409015
      Active, not recruiting
      ROTEM® Obstetric Hemorrhage Pilot Study
      Conditions: High Risk Postpartum Hemorrhage (PPH)
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations